Reaction monitoring of Antibody-Drug-Conjugates (ADCs) Using YMC´s BioPro HIC BF
contributed by YMC |
Drug-antibody ratio (DAR) of antibody-drug conjugates (ADCs) is important for their therapeutic efficacy and pharmacokinetics. Therefore control of DAR in the synthesis process is a key for ADC quality control. The ability to monitor this step reliably can also be advantageous for process understanding and control.
To provide a solution for this approach, RIKEN, the Japanese National Research and Development Agency successfully developed a method involving hydrophilic interaction chromatography (HIC) linked to UV/Vis spectroscopy (see table 1).
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.